Arrowhead Pharmaceuticals
ARWR
#1766
Rank
โ‚ฌ10.60 B
Marketcap
75,27ย โ‚ฌ
Share price
-1.36%
Change (1 day)
455.82%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): 0,88ย โ‚ฌ

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is 0,71ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,008793ย โ‚ฌ an increase over its 2024 EPS that were of -4,40ย โ‚ฌ.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)0,88ย โ‚ฌ-10157.88%
2025-0,008793ย โ‚ฌ-99.8%
2024-4,40ย โ‚ฌ161.39%
2023-1,68ย โ‚ฌ17.36%
2022-1,43ย โ‚ฌ19.85%
2021-1,20ย โ‚ฌ61.9%
2020-0,74ย โ‚ฌ-216.67%
20190,63ย โ‚ฌ-210.77%
2018-0,57ย โ‚ฌ38.3%
2017-0,41ย โ‚ฌ-64.93%
2016-1,18ย โ‚ฌ-16.25%
2015-1,41ย โ‚ฌ28%
2014-1,10ย โ‚ฌ-3.85%
2013-1,14ย โ‚ฌ-31.58%
2012-1,67ย โ‚ฌ331.82%
2011-0,39ย โ‚ฌ-51.11%
2010-0,79ย โ‚ฌ-79.07%
2009-3,78ย โ‚ฌ-37.68%
2008-6,07ย โ‚ฌ-16.87%
2007-7,30ย โ‚ฌ38.33%
2006-5,28ย โ‚ฌ122.22%
2005-2,37ย โ‚ฌ42.11%
2004-1,67ย โ‚ฌ533.33%
2003-0,26ย โ‚ฌ-99.08%
2002-28,55ย โ‚ฌ25%
2001-22,84ย โ‚ฌ33.33%
2000-17,13ย โ‚ฌ-120.87%
199982,08ย โ‚ฌ-400%
1998-27,36ย โ‚ฌ-81.48%
1997-147,75ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,68ย โ‚ฌ 978.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-7,17ย โ‚ฌ-1,106.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
6,89ย โ‚ฌ 867.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
3,33ย โ‚ฌ 367.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-2,00ย โ‚ฌ-380.25%๐Ÿ‡บ๐Ÿ‡ธ USA